Implant and Midterm Outcomes of the Subcutaneous Implantable Cardioverter-Defibrillator Registry

The subcutaneous implantable cardioverter-defibrillator (S-ICD) was developed to defibrillate ventricular arrhythmias, avoiding drawbacks of transvenous leads. The global EFFORTLESS S-ICD (Evaluation oF FactORs ImpacTing CLinical Outcome and Cost EffectiveneSS of the S-ICD) registry is collecting outcomes in 985 patients during a 5-year follow-up.The primary goal of the EFFORTLESS registry is to determine the safety of the S-ICD by evaluating...